Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Wierda

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1996
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugsJ H Proost, J M Wierda, D K Meijer
Anesthesia and Analgesia|March 11, 1999
Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488)S Schiere, J H Proost, M Schuringa, et al.
Anaesthesia|April 1, 1993
Vecuronium and rocuroniumL van den Broek, J M Wierda, P J Hennis
European Journal of Anaesthesiology. Supplement|January 1, 1994
Early and late reversibility of rocuronium bromideL van den Broek, J H Proost, J M Wierda
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1994
Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidismE J Roland, J M Wierda, B G Eurin, et al.
Anesthesia and Analgesia|June 1, 1995
Potency and onset of action of neuromuscular blocking drugsJ M Wierda, L van den Broek, S Schiere, et al.
European Journal of Anaesthesiology. Supplement|January 1, 1994
Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humansJ M Wierda, J H Proost, S Schiere, et al.
British Journal of Anaesthesia|April 1, 1990
Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agentJ M Wierda, A P de Wit, K Kuizenga, et al.
Anesthesiology|November 7, 1999
Rapid onset/offset of rapacuronium bromide explained?J H Proost, S Schiere, T M Beaufort, et al.
Anesthesiology|September 29, 2001
Predictability of processed electroencephalography effects on the basis of pharmacokinetic-pharmacodynamic modeling during repeated propofol infusions in patients with extradural analgesiaK Kuizenga, J H Proost, J M Wierda, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1996
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugsJ H Proost, J M Wierda, D K Meijer
Anesthesia and Analgesia|March 11, 1999
Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488)S Schiere, J H Proost, M Schuringa, et al.
Anaesthesia|April 1, 1993
Vecuronium and rocuroniumL van den Broek, J M Wierda, P J Hennis
European Journal of Anaesthesiology. Supplement|January 1, 1994
Early and late reversibility of rocuronium bromideL van den Broek, J H Proost, J M Wierda
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1994
Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidismE J Roland, J M Wierda, B G Eurin, et al.
Anesthesia and Analgesia|June 1, 1995
Potency and onset of action of neuromuscular blocking drugsJ M Wierda, L van den Broek, S Schiere, et al.
European Journal of Anaesthesiology. Supplement|January 1, 1994
Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humansJ M Wierda, J H Proost, S Schiere, et al.
British Journal of Anaesthesia|April 1, 1990
Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agentJ M Wierda, A P de Wit, K Kuizenga, et al.
Anesthesiology|November 7, 1999
Rapid onset/offset of rapacuronium bromide explained?J H Proost, S Schiere, T M Beaufort, et al.
Anesthesiology|September 29, 2001
Predictability of processed electroencephalography effects on the basis of pharmacokinetic-pharmacodynamic modeling during repeated propofol infusions in patients with extradural analgesiaK Kuizenga, J H Proost, J M Wierda, et al.
Pageof 8